Published in Neuropeptides on April 01, 2001
Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc Natl Acad Sci U S A (2004) 0.86
Amygdala nuclei critical for emotional learning exhibit unique gene expression patterns. Neurobiol Learn Mem (2013) 0.77
Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells). Biochem Pharmacol (2007) 0.75
Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand (2007) 4.51
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A (2006) 2.09
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A (1990) 1.79
Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord (2008) 1.78
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56
Organic mental disorders in HIV-1 infection. AIDS (1990) 1.45
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (1993) 1.43
Fluvoxamine increases plasma and urinary levels of clozapine and its major metabolites in a time- and dose-dependent manner. J Clin Psychopharmacol (2000) 1.41
Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology (2000) 1.41
Critique of the DSM-IV operational diagnostic criteria for schizophrenia. Br J Psychiatry (1998) 1.38
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res (1997) 1.33
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Burden on the families of patients with schizophrenia: results of the BIOMED I study. Soc Psychiatry Psychiatr Epidemiol (1998) 1.28
The cortical generators of P3a and P3b: a LORETA study. Brain Res Bull (2007) 1.23
Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport (1999) 1.18
Neuropeptide Y receptor subtypes, Y1 and Y2. Ann N Y Acad Sci (1990) 1.15
Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides (2002) 1.14
A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J (2004) 1.08
Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol (1999) 1.07
The impact of professional and social network support on the burden of families of patients with schizophrenia in Italy. Acta Psychiatr Scand (2002) 1.06
The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience (1999) 1.03
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett (2002) 1.02
Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence. Pharmacogenomics J (2012) 1.02
Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci Lett (1997) 1.00
The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol (2001) 1.00
High doses of testosterone increase anticonflict behaviour in rat. Eur Neuropsychopharmacol (1998) 1.00
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res (1997) 0.99
Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord (2004) 0.99
Cloning and molecular characterization of Dashurin encoded by C20orf116, a PCI-domain containing protein. Biochim Biophys Acta (2009) 0.99
Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides (2003) 0.99
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear. Neuroscience (2009) 0.98
cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur J Pharmacol (1994) 0.98
Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience (1998) 0.98
Anxiolytic-like action of centrally administered galanin. Neurosci Lett (1993) 0.98
Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Res (2000) 0.97
Family burden and coping strategies in schizophrenia: are key relatives really different to other relatives? Acta Psychiatr Scand (1999) 0.96
A new questionnaire assessing coping strategies in relatives of patients with schizophrenia: development and factor analysis. Acta Psychiatr Scand (1996) 0.94
Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J (2008) 0.94
Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry (2012) 0.94
Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol (1992) 0.94
Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med (2001) 0.93
Family burden and coping strategies in schizophrenia: 1-year follow-up data from the BIOMED I study. Soc Psychiatry Psychiatr Epidemiol (2000) 0.93
How to improve clinical practice on involuntary hospital admissions of psychiatric patients: suggestions from the EUNOMIA study. Eur Psychiatry (2010) 0.93
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology (Berl) (2011) 0.92
Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology (2001) 0.92
Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level. Life Sci (1983) 0.92
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept (1998) 0.92
Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology (1999) 0.92
Conditional associative learning in drug-free schizophrenic patients. Neuropsychobiology (1987) 0.91
Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology (2001) 0.91
Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study. Acta Psychiatr Scand (1998) 0.91
Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry (2009) 0.90
Activity, peroxide compound formation, and heme d synthesis in Escherichia coli HPII catalase. Arch Biochem Biophys (1997) 0.90
CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment. Schizophr Res (1991) 0.89
Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology (1990) 0.89
Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol (1999) 0.89
A multicenter Italian study of patients' relatives' beliefs about schizophrenia. Psychiatr Serv (2001) 0.89
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology (1998) 0.89
Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity. FASEB J (2006) 0.89
Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res (1987) 0.89
Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Acta Psychiatr Scand (1994) 0.88
Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience (1993) 0.88
Nociceptive changes in rats after prenatal exposure to valproic acid. Pol J Pharmacol (2002) 0.88
Effects of tiagabine and diazepam on operant ethanol self-administration in the rat. J Stud Alcohol (2002) 0.87
Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment. Cell Mol Life Sci (2005) 0.87
Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology (1994) 0.87
Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res (2001) 0.87
The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr (2010) 0.87
Social and clinical factors influencing the choice of coping strategies in relatives of patients with schizophrenia: results of the BIOMED I study. Soc Psychiatry Psychiatr Epidemiol (1998) 0.87
Insight and resistance in patients with obsessive-compulsive disorder. Psychopathology (2001) 0.87
Does bright light suppress nocturnal melatonin secretion more in women than men? J Neural Transm Gen Sect (1995) 0.87
[Cystic dysplasia of the testis: report of a case and review of the literature]. Arch Ital Urol Androl (2001) 0.87
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans. Life Sci (1990) 0.86
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology (2001) 0.86
Effects of depressed mood versus clinical depression on neuropsychological test performance among African American men impacted by HIV/AIDS. J Clin Exp Neuropsychol (1999) 0.86
Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions. Psychiatry Res (1996) 0.86
The search for candidate genes of alcoholism: evidence from expression profiling studies. Addict Biol (2005) 0.86
QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients. Biol Psychiatry (1994) 0.86
Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology (1997) 0.85
Burden on key relatives of patients with schizophrenia vs neurotic disorders: a pilot study. Soc Psychiatry Psychiatr Epidemiol (1994) 0.85
Qualitative MRI findings in patients with schizophrenia: a controlled study. Psychiatry Res (2000) 0.85
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. Genes Brain Behav (2009) 0.85
Family burden and social network in schizophrenia vs. physical diseases: preliminary results from an Italian national study. Acta Psychiatr Scand Suppl (2006) 0.85
Psychological consequences of the 1998 landslide in Sarno, Italy: a community study. Acta Psychiatr Scand (2001) 0.85
Levosulpiride: a review of its clinical use in psychiatry. Pharmacol Res (1995) 0.85
The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci (2000) 0.85
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat. Eur J Pharmacol (1987) 0.84
Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype. Hum Genet (2009) 0.84
Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med (2003) 0.84
Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus. Neuropharmacology (2002) 0.83
Decreased measures of experimental anxiety in rats bred for high alcohol preference. Alcohol Clin Exp Res (1997) 0.83
Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats. Mol Psychiatry (2001) 0.83
Depression, substance use, and sexual orientation as cofactors in HIV-1 infected men: cross-cultural comparisons. NIDA Res Monogr (1997) 0.83
Evolution of the American concept of schizoaffective psychosis. Neuropsychobiology (1984) 0.83
Intracerebroventricular galanin and N-terminal galanin fragment enhance the morphine-induced analgesia in the rat. J Neural Transm Gen Sect (1995) 0.83
[Family burden in schizophrenia: effects of socio-environmental and clinical variables and family intervention]. Epidemiol Psichiatr Soc (1999) 0.83
Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther (1997) 0.83